We serve Chemical Name:N-[2-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide CAS:13642-52-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![N-[2-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide](https://a.dearchem.com/CAS2/13642-52-9.png)
Chemical Name:N-[2-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide
CAS.NO:13642-52-9
Synonyms:N-[2-hydroxy-5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]methanesulfonamide;SOTERENOL;Soterenolum [INN-Latin];UNII-9364W7589B;2′-hydroxy-5′-[1-hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide;Soterenol [INN];Soterenolum
Molecular Formula:C12H20N2O4S
Molecular Weight:288.36300
HS Code:2935009090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:477ºC at 760mmHg
Density:1.321g/cm3
Index of Refraction:1.59
PSA:107.04000
Exact Mass:288.11400
LogP:2.33980
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-[2-hydroxy-5-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]methanesulfonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Soterenolum physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Soterenolum Use and application,SOTERENOL technical grade,usp/ep/jp grade.
Related News: The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. N-(3,4,5-trimethoxyphenyl)thiomorpholine-4-carboxamide manufacturers Throughout the pandemic, our site remained fully operational while keeping our employees safe and having a positive impact on human health. Our expanded facility will provide us with the increased capacity needed to continue the essential services we provide to our clients” Fmoc-Phe-N(CH3)-OCH3 suppliers In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. 10-chloro-2-phenyl-6H-chromeno[3,4-e]pyrazolo[1,5-a]pyrimidine vendor & factory.
